Human Leukocyte Antigen Testing Market Global Report 2021, 28

Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Services (Reagents & Consumables, Instruments, and Software & Services), Technology [Molecular Assay Technologies (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, and Others) and Non-Molecular Assay Technologies], and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others), and Geography

Publication Month: May 2022 | Report Code: TIPRE00021578 | No. of Pages: 221 | Category: Biotechnology | Status: Published

The human leukocyte antigen (HLA) testing market is projected to reach US$ 1,155.65 million by 2028 from US$ 697.74 million in 2021; it is expected to register a CAGR of 7.5% from 2022 to 2028.

Human leukocyte antigens play an essential part in the body's immune response to external substances. The principal use for HLA testing is to match organ and tissue transplant recipients with compatible donors. The HLA testing also involves screening transplant recipients for the presence of antibodies that might target the donated tissue or organ as part of an immune response.

The report offers insights and in-depth analysis of the human leukocyte antigen (HLA) testing market emphasizing market trends, technological advancements, and market dynamics, among others. It also provides the competitive landscape analysis of the globally leading market players. Furthermore, it includes the impact of the COVID-19 pandemic on the market across all the major regions. The COVID-19 pandemic created both a public health crisis and an economic crisis worldwide. Before the pandemic, the human leukocyte antigen (HLA) testing market was growing continuously owing to the regularity in the assessment of organ donors, consolations, and treatments. The first wave of COVID-19 disrupted the consultations, follow-ups, and screenings related to diseases other than COVID-19. Several companies experienced severe losses in the last quarter of 2019; the pandemic particularly had adverse effects on the global market in the first and second quarters of 2020. Businesses worldwide were hampered due to disruption in supply chains, and increased demand for healthcare products and services. To reduce COVID-19 infection in hospitals and clinics, healthcare practitioners and patients adopted and preferred treating their patients remotely. These unforeseeable circumstances also hampered organ transplantation procedures. Many surgical treatments and non-urgent consultations were canceled or postponed, and elective surgeries were suspended in many institutions to limit the spread of SARS-CoV-2 as well as to reserve and reallocate resources, including healthcare personnel (nurses and anesthesiologists), medical equipment (personal protective equipment and ventilators), and beds. The "stay at home" recommendation resulted in a significant reduction in organ donation and organ transplantation surgeries. These conditions restrained the growth of the human leukocyte antigen (HLA) testing market worldwide in 2020.

Strategic Insights

Lucrative Regions for human leukocyte antigen (HLA) testing market

Lucrative Regions for human leukocyte antigen (HLA) testing market

Get more information on this report :

Market Insights
Increasing Number of Plasma Donation and Organ Transplantation Procedures Drive Market Growth

Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants.

Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For Instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization.

Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.

Product and Services-Based Insights

Based on product and services, the human leukocyte antigen (HLA) testing market is segmented into reagents and consumables, instruments, and software and services. In 2021, the reagents and consumables segment held the largest share of the market, and it is expected to register the fastest CAGR of 7.5% during the forecast period.

Human leukocyte antigen (HLA) testing market, by Product and Services – 2022 and 2028

Human leukocyte antigen (HLA) testing market, by Product and Services – 2022 and 2028

Get more information on this report :

Technology-Based Insights

Based on technology, the human leukocyte antigen (HLA) testing market is segmented into molecular assay technologies and non-molecular assay technologies. In 2021, the molecular assay technologies segment held a largest share of the market, and it is expected to record a higher CAGR of 7.7% during 2022–2028.

End User-Based Insights

Based on end user, the human leukocyte antigen (HLA) testing market is segmented into independent reference laboratories, hospitals and transplant centers, and others. In 2021, the independent reference laboratories segment held the largest share of the market. However, hospitals and transplant centers segment is expected to report the highest CAGR of 7.9% during 2022–2028

The human leukocyte antigen (HLA) testing market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide, along with meeting the growing product demands.

By Geography

Based on geography, the human leukocyte antigen (HLA) testing market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company Profiles

  • Thermo Fisher Scientific Inc.
  • CareDx
  • Qiagen
  • Illumina Inc.
  • Bio-Rad Laboratories, Inc.
  • TBG Diagnostics Limited
  • F.Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Luminex Corporation
  • Omixon Inc.
  • The Sequencing Center
  • Protrans
  • HistoGenetics LLC.
  • CD Genomics
  • Qunitara Biosciences
  • CeGat GmbH
  • Creative Biolabs Inc.

Frequently Asked Questions

Human leukocyte antigens play an essential part in the body's immune response to external substances. The principal use for human leukocyte antigen (HLA) testing is to match organ and tissue transplant recipients with compatible donors. HLA testing also involves screening transplant recipients for the presence of antibodies that might target the donated tissue or organ as part of an immune response.
Increasing plasma donation and organ transplants procedures is one of the most significant factors responsible for the overall market growth.
Based on product and service type, reagent and consumables took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
The molecular assay technologies segment dominated the global human leukocyte antigen (HLA) testing market and is likely to account for the revenue of US$ 626.86 million in 2022.
Thermo Fisher Scientific, Inc., CareDx, Inc., Qiagen N.V., Illumina, Bio-Rad Laboratories, Inc., TGB Diagnostics Ltd., F. Hoffman La-Roche Ltd., Takara Bio, Luminex Corporation, Oximon, The Sequencing Center, Protrans, HistoGenetics LLC, CD Genomics, Quintara Biosciences, CeGaT GmbH, Creative Biolabs, Inc., are among the leading companies operating in the global human leukocyte antigen (HLA) testing market
Global human leukocyte antigen (HLA) testing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for human leukocyte antigen (HLA) testing market. The US is estimated to hold the largest share in the human leukocyte antigen (HLA) testing market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia-Pacific regional growth for human leukocyte antigen (HLA) testing accounting fastest growth of the region during the coming years.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market – By Product and Services

1.3.2 Global Human Leukocyte Antigen (HLA) Testing Market – By Technology

1.3.3 Global Human Leukocyte Antigen (HLA) Testing Market – By End User

1.3.4 Global Human Leukocyte Antigen (HLA) Testing Market – By Geography

2. Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Human Leukocyte Antigen (HLA) Testing Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South & Central America – PEST Analysis

4.3 Expert Opinion

5. Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures

5.1.2 Expanding Range of Applications of HLA Testing

5.2 Market Restraints

5.2.1 Errors in Accuracy

5.3 Market Opportunities

5.3.1 Rising Government Funding for Organ Donation

5.4 Future Trends

5.4.1 Technological Advancements in Field of Histocompatibility

5.5 Impact Analysis

6. Global Human Leukocyte Antigen (HLA) Testing Market – Global Analysis

6.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis

6.1.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis

6.1.2 Global Human Leukocyte Antigen (HLA) Testing Market – Market Potential Analysis, By Region

6.2 Company Analysis

6.2.1 Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance of Key Players

6.2.4.1 Thermo Fisher Scientific Inc

6.2.4.2 Illumina Corporation

7. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services

7.1 Overview

7.2 Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)

7.3 Reagents and Consumables

7.3.1 Overview

7.3.2 Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

8. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology

8.1 Overview

8.2 Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)

8.3 Molecular Assay Technologies

8.3.1 Overview

8.3.2 Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.3 PCR-Based Molecular Assays

8.3.3.1 Overview

8.3.3.2 PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.4 Sequencing-Based Molecular Assays

8.3.4.1 Overview

8.3.4.2 Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.5 Others

8.3.5.1 Overview

8.3.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Non-Molecular Assay Technologies

8.4.1 Overview

8.4.2 Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User

9.1 Overview

9.2 Global Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)

9.3 Independent Reference Laboratories

9.3.1 Overview

9.3.2 Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.4 Hospital & Transplant Centers

9.4.1 Overview

9.4.2 Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Geography

10.1 North America: Human Leukocyte Antigen (HLA) Testing Market

10.1.1 Overview

10.1.2 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.4 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.4.1 North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.5 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6 North America: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.1.6.1 US: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.1.3 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.3.1 US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.4 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.2 Canada: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.2.3 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.3.1 Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.4 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Mexico Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.3.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.3.1 Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.4 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2 Europe: Human Leukocyte Antigen (HLA) Testing Market

10.2.1 Overview

10.2.2 Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.4 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.4.1 Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.5 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6 Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.2.6.1 Germany: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Germany: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.2 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.1.3 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.1.3.1 Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.1.4 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.2 France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.2 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.2.3 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.2.3.1 France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.2.4 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.3 UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.2 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.3.3 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.3.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.3.4 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.4 Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.2 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.4.3 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.4.3.1 Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.4.4 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.5 Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.2 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.5.3 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.5.3.1 Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.5.4 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.6 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.2 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.6.3 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.6.3.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.6.4 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.3 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028

10.3.1 Overview

10.3.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.3 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.3.4 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.4.1 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.5 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)

10.3.6.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

10.3.6.1.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.2 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.1.3 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.1.3.1 China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.1.4 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.1 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.2.3 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.2.3.1 Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.2.4 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.3 India Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

10.3.6.3.1 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.2 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.3.3 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.3.3.1 India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.3.4 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

10.3.6.4.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.2 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.4.3 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.4.3.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.4.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.5 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.1 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.2 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.5.3 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.5.3.1 Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.5.4 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.6 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.2 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.6.3.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market

10.4.1 Overview

10.4.2 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)

10.4.3 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.4.1 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.5 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.4.6.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.2 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.1.3 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.1.3.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.1.4 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.2 UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.1 UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.2 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.2.3 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.2.3.1 UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.2.4 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.2 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.3.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.3.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.3.4 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.2 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.4.3 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.4.3.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.4.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.5 South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028

10.5.1 Overview

10.5.2 South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.3 South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.5.4 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.4.1 South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.5 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.5.6 South and Central America: Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)

10.5.6.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.2 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)

10.5.6.1.3 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.6.1.4 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)

10.5.6.2.3 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.6.2.4 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.2 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)

10.5.6.3.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.6.3.4 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Geographic Regions

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment Of COVID-19 Pandemic

11.4 Middle East & Africa: Impact Assessment Of COVID-19 Pandemic

11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 CareDx

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Illumina, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bio-Rad Laboratories, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 TBG Diagnostics Limited

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 F. HOFFMANN-LA ROCHE LTD.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Takara Bio Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Luminex Corporation

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Omixon Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 The Sequencing Center

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Protrans

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 HistoGenetics LLC

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 CD Genomics

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Quintara Biosciences

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

13.16 CeGaT GmbH

13.16.1 Key Facts

13.16.2 Business Description

13.16.3 Products and Services

13.16.4 Financial Overview

13.16.5 SWOT Analysis

13.16.6 Key Developments

13.17 CREATIVE BIOLABS, INC.

13.17.1 Key Facts

13.17.2 Business Description

13.17.3 Products and Services

13.17.4 Financial Overview

13.17.5 SWOT Analysis

13.17.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 2. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 3. North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 4. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 5. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 6. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 7. US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 8. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 9. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 10. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 11. Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 12. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 13. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 14. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 15. Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 16. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 17. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 18. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 19. Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 20. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 21. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 22. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 23. Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 24. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 25. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 26. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 27. France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 28. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 29. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 30. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 31. UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 32. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 33. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 34. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 35. Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 36. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 37. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 38. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 39. Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 40. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 41. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 42. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 43. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 44. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 45. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 46. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 47. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 48. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 49. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 50. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 51. China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 52. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 53. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 54. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 55. Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 56. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 57. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 58. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 59. India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 60. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 61. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 62. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 63. South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 64. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 65. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 66. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 67. Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 68. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 69. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 70. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 71. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 72. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 73. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 74. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 75. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 76. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 77. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 78. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 79. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 80. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 81. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 82. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 83. UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 84. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 85. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 86. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 87. South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 88. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 89. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 90. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 91. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 92. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 93. South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 94. South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 95. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 96. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 97. Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 98. Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 99. Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 100. Brazil: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 101. Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 102. Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 103. Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 104. Argentina: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 105. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 106. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 107. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 108. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 109. Organic Developments in the Human Leukocyte Antigen (HLA) Testing Market

Table 110. Inorganic Developments in the Human Leukocyte Antigen (HLA) Testing Market

Table 111. Glossary of Terms, Human Leukocyte Antigen (HLA) Testing Market

LIST OF FIGURES

Figure 1. Human Leukocyte Antigen (HLA) Testing Market Segmentation

Figure 2. Human Leukocyte Antigen (HLA) Testing Market Segmentation, By Region

Figure 3. Global Human Leukocyte Antigen (HLA) Testing Market Overview

Figure 4. Reagents And Consumables Held Largest Share of Product Segment in Human Leukocyte Antigen (HLA) Testing Market

Figure 5. Asia Pacific Region is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Global Human Leukocyte Antigen (HLA) Testing Market, By Geography (US$ Million)

Figure 7. Global Human Leukocyte Antigen (HLA) Testing Market- Leading Country Markets (US$ Million)

Figure 8. Global Human Leukocyte Antigen (HLA) Testing Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East & Africa: PEST Analysis

Figure 13. South & Central America: PEST Analysis

Figure 14. Experts’ Opinion

Figure 15. HLA Testing Market: Impact Analysis of Drivers and Restraints

Figure 16. Global Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2020- 2028

Figure 17. Global Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 18. Global Human Leukocyte Antigen (HLA) Testing Market – Market Potential Analysis, By Region

Figure 19. Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market

Figure 20. Global Human Leukocyte Antigen (HLA) Testing Market – Comparative Company Analysis

Figure 21. Global Human Leukocyte Antigen (HLA) Testing Market – Growth Strategy Analysis

Figure 22. Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)

Figure 23. Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 24. Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 25. Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 26. Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)

Figure 27. Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 31. Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 32. Global Human Leukocyte Antigen (HLA) Testing Market Share, By End User 2022 & 2028 (%)

Figure 33. Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 34. Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 35. Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 36. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)

Figure 37. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 38. North America: Human Leukocyte Antigen (HLA) Testing Market, By Country, 2022 & 2028 (%)

Figure 39. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 40. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 41. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 42. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)

Figure 43. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 44. Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

Figure 45. Germany: Human Leukocyte Antigen (HLA) Testing Products Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)

Figure 52. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 53. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)

Figure 54. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 55. Japan Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 56. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 57. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 58. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 59. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast To 2028 (US$ Million)

Figure 60. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Key Country – Revenue (2022) (US$ Million)

Figure 61. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 62. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

Figure 63. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64. UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 65. South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 66. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 67. South and Central America Human Leukocyte Antigen (HLA) Testing Market Overview, by Country (2022)

Figure 68. South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 69. South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)

Figure 70. Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 71. Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 72. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 73. Impact of COVID-19 Pandemic on North American Country Markets

Figure 74. Impact of COVID-19 Pandemic on European Country Markets

Figure 75. Impact of COVID-19 Pandemic on Asia Pacific Country Markets

Figure 76. Impact of COVID-19 Pandemic on Middle East & Africa Country Markets

Figure 77. Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 78. Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)

The List of Companies - Human Leukocyte Antigen (HLA) Market

  1. Thermo Fisher Scientific Inc.
  2. CareDx
  3. Qiagen
  4. Illumina Inc.
  5. Bio-Rad Laboratories, Inc.
  6. TBG Diagnostics Limited
  7. F.Hoffmann-La Roche Ltd.
  8. Takara Bio Inc.
  9. Luminex Corporation
  10. Omixon Inc.
  11. The Sequencing Center
  12. Protrans
  13. HistoGenetics LLC.
  14. CD Genomics
  15. Qunitara Biosciences
  16. CeGat GmbH
  17. Creative Biolabs Inc.   
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global human leukocyte antigen (HLA) market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global human leukocyte antigen (HLA) market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00021578
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount